Evidence map›Paper›PMID 34006297›Full record

ArticleMalaria journal2021

Optimization of Plasmodium vivax sporozoite production from Anopheles stephensi in South West India.

Ajeet Kumar Mohanty, Charles de Souza, Deepika Harjai, Prathamesh Ghavanalkar, Mezia Fernandes, Anvily Almeida, Jayashri Walke, Suresh Kumar Manoharan, Ligia Pereira, Rashmi Dash and 9 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Assessment of antibiotic treatment onFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Ajeet Kumar MohantyField Unit, National Institute of Malaria Research, Campal, Goa, 403001, India. ajitbiotech1@gmail.com.
Charles de SouzaField Unit, National Institute of Malaria Research, Campal, Goa, 403001, India.
Deepika HarjaiField Unit, National Institute of Malaria Research, Campal, Goa, 403001, India.
Prathamesh GhavanalkarField Unit, National Institute of Malaria Research, Campal, Goa, 403001, India.
Mezia FernandesGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Anvily AlmeidaGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Jayashri WalkeGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Suresh Kumar ManoharanGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Ligia PereiraGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Rashmi DashGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Anjali MascarenhasGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Edwin GomesGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Thanyapit ThitaDrug Research Unit for Malaria (DRUM), Center of Excellence in Malaria Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.
Laura CheryDepartment of Chemistry, University of Washington, Seattle, WA, 98195, USA.
Anupkumar R AnvikarNational Institute of Malaria Research (ICMR), Sector 8, Dwarka, New Delhi, 110077, India.
Ashwani KumarField Unit, National Institute of Malaria Research, Campal, Goa, 403001, India.
Neena ValechaNational Institute of Malaria Research (ICMR), Sector 8, Dwarka, New Delhi, 110077, India.
Pradipsinh K RathodDepartment of Chemistry, University of Washington, Seattle, WA, 98195, USA.
Rapatbhorn PatrapuvichDrug Research Unit for Malaria (DRUM), Center of Excellence in Malaria Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand. rapatbhorn.pat@mahidol.edu.ORCID http://orcid.org/0000-0001-8214-5710
University of Washington · USNational Institute of Malaria Research · INMahidol University · THGoa Medical College · INVector Control Research Centre · IN

Funding

Shared TechnologyU19AI089688 · NIAID · UNIVERSITY OF WASHINGTON · PI RATHOD, PRADIPSINH K. · 2010 to 2023
$22.4M
NIAID NIH HHS U19 AI089688
6 · The paper itself

Abstract

backgroundEfforts to study the biology of Plasmodium vivax liver stages, particularly the latent hypnozoites, have been hampered by the limited availability of P. vivax sporozoites. Anopheles stephensi is a major urban malaria vector in Goa and elsewhere in South Asia. Using P. vivax patient blood samples, a series of standard membrane-feeding experiments were performed with An. stephensi under the US NIH International Center of Excellence for Malaria Research (ICEMR) for Malaria Evolution in South Asia (MESA). The goal was to understand the dynamics of parasite development in mosquitoes as well as the production of P. vivax sporozoites. To obtain a robust supply of P. vivax sporozoites, mosquito-rearing and mosquito membrane-feeding techniques were optimized, which are described here.

methodsMembrane-feeding experiments were conducted using both wild and laboratory-colonized An. stephensi mosquitoes and patient-derived P. vivax collected at the Goa Medical College and Hospital. Parasite development to midgut oocysts and salivary gland sporozoites was assessed on days 7 and 14 post-feeding, respectively. The optimal conditions for mosquito rearing and feeding were evaluated to produce high-quality mosquitoes and to yield a high sporozoite rate, respectively.

resultsLaboratory-colonized mosquitoes could be starved for a shorter time before successful blood feeding compared with wild-caught mosquitoes. Optimizing the mosquito-rearing methods significantly increased mosquito survival. For mosquito feeding, replacing patient plasma with naïve serum increased sporozoite production > two-fold. With these changes, the sporozoite infection rate was high (> 85%) and resulted in an average of ~ 22,000 sporozoites per mosquito. Some mosquitoes reached up to 73,000 sporozoites. Sporozoite production could not be predicted from gametocyte density but could be predicted by measuring oocyst infection and oocyst load.

conclusionsOptimized conditions for the production of high-quality P. vivax sporozoite-infected An. stephensi were established at a field site in South West India. This report describes techniques for producing a ready resource of P. vivax sporozoites. The improved protocols can help in future research on the biology of P. vivax liver stages, including hypnozoites, in India, as well as the development of anti-relapse interventions for vivax malaria.

Indexed as

AnimalsAnophelesFemaleIndiaMosquito VectorsPlasmodium vivaxSporozoitesAnopheles stephensiInsectaryMembrane-feeding assaysPlasmodium vivaxSporozoite

Identifiers

PMID34006297
PMCPMC8129701
OpenAlexW3162412338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.